Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MIFEPRISTONE Cause Malignant neoplasm progression? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Malignant neoplasm progression have been filed in association with MIFEPRISTONE (Mifepristone). This represents 0.2% of all adverse event reports for MIFEPRISTONE.

7
Reports of Malignant neoplasm progression with MIFEPRISTONE
0.2%
of all MIFEPRISTONE reports
2
Deaths
2
Hospitalizations

How Dangerous Is Malignant neoplasm progression From MIFEPRISTONE?

Of the 7 reports, 2 (28.6%) resulted in death, 2 (28.6%) required hospitalization, and 1 (14.3%) were considered life-threatening.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MIFEPRISTONE. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does MIFEPRISTONE Cause?

Nausea (709) Fatigue (627) Abortion incomplete (533) Haemorrhage (527) Blood potassium decreased (411) Vomiting (376) Dizziness (375) Headache (365) Pain (314) Blood pressure increased (311)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Which MIFEPRISTONE Alternatives Have Lower Malignant neoplasm progression Risk?

MIFEPRISTONE vs MIGALASTAT MIFEPRISTONE vs MIGLITOL MIFEPRISTONE vs MIGLUSTAT MIFEPRISTONE vs MILNACIPRAN MIFEPRISTONE vs MILRINONE

Related Pages

MIFEPRISTONE Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression MIFEPRISTONE Demographics